Straits Times Index
3,309.92 +9.92 (+0.30%) Nikkei
38,582.32 -50.70 (-0.13%) Hang Seng
18,065.39 -269.93 (-1.47%) FTSE 100
8,272.46 +67.35 (+0.82%) Bitcoin USD
64,582.16 -931.80 (-1.42%) CMC Crypto 200
1,353.21 -7.11 (-0.52%)
PCRX Nov 2024 40.000 call
- Simply Wall St.
Declining Stock and Decent Financials: Is The Market Wrong About Pacira BioSciences, Inc. (NASDAQ:PCRX)?
With its stock down 7.9% over the past month, it is easy to disregard Pacira BioSciences (NASDAQ:PCRX). However, stock...
- GuruFocus.com
Insider Sale: Chief Medical Officer Jonathan Slonin Sells Shares of Pacira BioSciences Inc (PCRX)
Jonathan Slonin, Chief Medical Officer of Pacira BioSciences Inc (NASDAQ:PCRX), executed a sale of 5,012 shares of the company on June 11, 2024, as reported in a recent SEC Filing.
- GlobeNewswire
Pacira BioSciences to Participate in Fireside Chat at the 2024 Jefferies Global Healthcare Conference
TAMPA, Fla., May 30, 2024 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (NASDAQ: PCRX) today announced that it will participate in an analyst-led fireside chat at the 2024 Jefferies Global Healthcare Conference at 11:00 AM ET on Thursday, June 6, 2024 in New York. Live audio of the event can be accessed by visiting the “Events” page of the company’s website at investor.pacira.com. A replay of the webcast will also be available for two weeks following the event. About Pacira Pacira BioSciences, In
